Frontiers in Oncology,
Год журнала:
2024,
Номер
14
Опубликована: Фев. 26, 2024
Ferroptosis
differs
from
traditional
cell
death
mechanisms
like
apoptosis,
necrosis,
and
autophagy,
primarily
due
to
its
reliance
on
iron
metabolism
the
loss
of
glutathione
peroxidase
activity,
leading
lipid
peroxidation
death.
The
dysregulation
is
a
hallmark
various
cancers,
contributing
tumor
progression,
metastasis,
notably,
drug
resistance.
acquisition
mesenchymal
characteristics
by
epithelial
cells
known
as
Epithelial–Mesenchymal
Transition
(EMT),
biological
process
intricately
linked
cancer
development,
promoting
traits
such
invasiveness,
resistance
therapeutic
interventions.
EMT
plays
pivotal
role
in
progression
contributes
significantly
complex
dynamics
carcinogenesis.
Research
findings
indicate
that
exhibit
greater
susceptibility
ferroptosis
compared
their
counterparts.
induction
becomes
more
effective
eliminating
drug-resistant
during
EMT.
interplay
between
EMT,
where
transform
into
mobile
cells,
crucial
understanding
progression.
associated
with
increased
metastasis
review
delves
how
influence
each
other,
highlighting
key
proteins
GPX4,
which
protects
against
peroxidation,
inhibition
can
induce
ferroptosis.
Conversely,
GPX4
expression
heightened
cells.
Moreover,
discusses
implications
EMT-induced
transcription
factors
Snail,
Zeb1,
Twist
modulating
sensitivity
ferroptosis,
thereby
affecting
treatment
outcomes.
Targeting
pathway
offers
promising
strategy,
particularly
for
tumors
resistant
conventional
treatments.
these
could
potentially
overcome
However,
translating
clinical
practice
presents
challenges,
including
precise
induction,
identifying
predictive
biomarkers,
optimizing
combination
therapies.
underscores
need
further
research
unravel
interactions
cancer.
This
lead
development
effective,
targeted
treatments,
tumors,
offering
new
hope
therapeutics.
Cell Death and Disease,
Год журнала:
2023,
Номер
14(8)
Опубликована: Авг. 14, 2023
Abstract
Ferroptosis
is
a
form
of
regulated
cell
death
induced
by
iron-dependent
lipid
peroxidation,
and
it
has
been
studied
extensively
since
its
discovery
in
2012.
Induced
iron
overload
ROS
accumulation,
ferroptosis
modulated
various
cellular
metabolic
signaling
pathways.
The
GSH-GPX4
pathway,
the
FSP1-CoQ10
GCH1-BH4
DHODH-CoQH2
system
sex
hormones
suppress
ferroptosis.
Mitochondrial
metabolism
regulates
mitochondria
also
undergo
morphological
change
during
ferroptosis,
these
changes
include
increased
membrane
density
reduced
mitochondrial
cristae.
Moreover,
energy
oxidative
phosphorylation
ATP
production
rates
lead
to
decrease
glycolysis
rate.
In
addition,
excessive
stress
induces
irreversible
damage
mitochondria,
diminishing
organelle
integrity.
production,
potential,
fusion
fission,
mitophagy
function
Notably,
some
inhibitors
target
mitochondria.
major
mechanism
for
associated
with
progression
cancer.
Metastasis-prone
or
metastatic
cancer
cells
are
more
susceptible
Inducing
tumor
shows
very
promising
potential
treating
drug-resistant
cancers.
this
review,
we
present
brief
retrospect
characteristics
then
discuss
regulation
highlight
unique
role
played
cells.
Furthermore,
explain
how
functions
as
double-edged
sword
well
novel
therapies
aimed
at
selectively
manipulating
eradication.
Antioxidants,
Год журнала:
2022,
Номер
11(12), С. 2444 - 2444
Опубликована: Дек. 11, 2022
SLC7A11
is
a
cell
transmembrane
protein
composing
the
light
chain
of
system
xc-,
transporting
extracellular
cystine
into
cells
for
cysteine
production
and
GSH
biosynthesis.
critical
gateway
redox
homeostasis
by
maintaining
cellular
levels
that
counter
oxidative
stress
suppress
ferroptosis.
overexpressed
in
various
human
cancers
regulates
tumor
development,
proliferation,
metastasis,
microenvironment,
treatment
resistance.
Upregulation
needed
to
adapt
high
microenvironments
maintain
homeostasis.
High
basal
ROS
dependences
cancer
render
them
vulnerable
further
stress.
Therefore,
cyst(e)ine
depletion
may
be
an
effective
new
strategy
treatment.
However,
effectiveness
inhibitors
or
cyst(e)inase
has
been
established
many
preclinical
studies
but
not
reached
stage
clinical
trials
patients.
A
better
understanding
functions
regulating
interacting
with
redox-active
proteins
their
substrates
could
promising
this
review
intends
understand
role
antioxidant
signaling,
regulators
bioavailability
cancer,
linking
signaling
metabolism
targeting
novel
therapeutics.
Cellular and Molecular Neurobiology,
Год журнала:
2023,
Номер
43(7), С. 3329 - 3341
Опубликована: Июль 17, 2023
Abstract
Ferroptosis
is
a
new
form
of
programmed
cell
death,
which
characterized
by
the
iron-dependent
accumulation
lipid
peroxidation
and
increase
ROS,
resulting
in
oxidative
stress
death.
Iron,
lipid,
multiple
signaling
pathways
precisely
control
occurrence
implementation
ferroptosis.
The
mainly
include
Nrf2/HO-1
pathway,
p62/Keap1/Nrf2
pathway.
Activating
pathway
inhibits
promotes
Furthermore,
some
factors
also
participate
ferroptosis
under
hypoxia,
such
as
HIF-1,
NCOA4,
DMT1.
Meanwhile,
related
with
hypoxia-related
diseases,
MIRI,
cancers,
AKI.
Accordingly,
appears
to
be
therapeutic
target
for
diseases.
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
174, С. 116512 - 116512
Опубликована: Апрель 3, 2024
GPX4
(Glutathione
peroxidase
4)
serves
as
a
crucial
intracellular
regulatory
factor,
participating
in
various
physiological
processes
and
playing
significant
role
maintaining
the
redox
homeostasis
within
body.
Ferroptosis,
form
of
iron-dependent
non-apoptotic
cell
death,
has
gained
considerable
attention
recent
years
due
to
its
involvement
multiple
pathological
processes.
is
closely
associated
with
ferroptosis
functions
primary
inhibitor
this
process.
Together,
contribute
pathophysiology
several
diseases,
including
sepsis,
nervous
system
ischemia
reperfusion
injury,
cardiovascular
cancer.
This
review
comprehensively
explores
roles
impacts
development
progression
these
aim
providing
insights
for
identifying
potential
therapeutic
strategies
future.
Cell Death Discovery,
Год журнала:
2023,
Номер
9(1)
Опубликована: Апрель 1, 2023
Lung
cancer
is
a
common
malignant
tumor
that
occurs
in
the
human
body
and
poses
serious
threat
to
health
quality
of
life.
The
existing
treatment
methods
mainly
include
surgical
treatment,
chemotherapy,
radiotherapy.
However,
due
strong
metastatic
characteristics
lung
emergence
related
drug
resistance
radiation
resistance,
overall
survival
rate
patients
not
ideal.
There
an
urgent
need
develop
new
strategies
or
effective
drugs
treat
cancer.
Ferroptosis,
novel
type
programmed
cell
death,
different
from
traditional
death
pathways
such
as
apoptosis,
necrosis,
pyroptosis
so
on.
It
caused
by
increase
iron-dependent
reactive
oxygen
species
intracellular
iron
overload,
which
leads
accumulation
lipid
peroxides,
thus
inducing
membrane
oxidative
damage,
affecting
normal
life
process
cells,
finally
promoting
ferroptosis.
regulation
ferroptosis
closely
physiological
it
involves
metabolism,
balance
between
oxygen-free
radical
reaction
peroxidation.
A
large
number
studies
have
confirmed
result
combined
action
cellular
oxidation/antioxidant
system
damage/repair,
has
great
potential
application
therapy.
Therefore,
this
review
aims
explore
therapeutic
targets
for
clarifying
regulatory
pathway
Based
on
study
ferroptosis,
mechanism
was
understood
chemical
natural
compounds
targeting
were
summarized,
with
aim
providing
ideas
In
addition,
also
provides
basis
discovery
clinical
effectively
Ageing Research Reviews,
Год журнала:
2023,
Номер
91, С. 102035 - 102035
Опубликована: Авг. 23, 2023
Ferroptosis
is
an
iron-
and
lipid
peroxidation
(LPO)-mediated
programmed
cell
death
type.
Recently,
mounting
evidence
has
indicated
the
involvement
of
ferroptosis
in
neurodegenerative
diseases,
especially
Alzheimer's
disease
(AD),
Parkinson's
(PD),
multiple
sclerosis
(MS),
amyotrophic
lateral
(ALS),
Huntington's
(HD),
so
on.
Treating
presents
opportunities
as
well
challenges
for
diseases.
This
review
provides
a
comprehensive
overview
underlying
mechanisms
that
contribute
to
occurrence
ferroptosis,
their
implications
pathogenesis
advancement
major
disorders.
Meanwhile,
we
summarize
interaction
between
other
types
diseases
contribution
corresponding
drug
development.
In
addition,
specifically
recent
advances
developing
therapeutic
means
targeting
these
which
may
guide
future
approaches
effective
management
devastating
medical
conditions.
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
171, С. 116112 - 116112
Опубликована: Янв. 2, 2024
Ferroptosis
is
a
newly
identified
form
of
non-apoptotic
programmed
cell
death,
characterized
by
the
iron-dependent
accumulation
lethal
lipid
reactive
oxygen
species
(ROS)
and
peroxidation
membrane
polyunsaturated
fatty
acid
phospholipids
(PUFA-PLs).
unique
among
other
death
modalities
in
many
aspects.
It
initiated
excessive
oxidative
damage
due
to
iron
overload
compromised
antioxidant
defense
systems,
including
system
Xc-/
glutathione
(GSH)/glutathione
peroxidase
4
(GPX4)
pathway
GPX4-independent
pathways.
In
past
ten
years,
ferroptosis
was
reported
play
critical
role
pathogenesis
various
cardiovascular
diseases,
e.g.,
atherosclerosis
(AS),
arrhythmia,
heart
failure,
diabetic
cardiomyopathy,
myocardial
ischemia-reperfusion
injury.
Studies
have
dysfunctional
metabolism
abnormal
expression
profiles
ferroptosis-related
factors,
iron,
GSH,
GPX4,
ferroportin
(FPN),
SLC7A11
(xCT),
as
indicators
for
atherogenesis.
Moreover,
plaque
cells,
i.e.,
vascular
endothelial
(VEC),
macrophage,
smooth
muscle
(VSMC),
positively
correlate
with
atherosclerotic
development.
Many
macromolecules,
drugs,
Chinese
herbs,
food
extracts
can
inhibit
atherogenic
process
suppressing
cells.
contrast,
some
inducers
significant
pro-atherogenic
effects.
However,
mechanisms
through
which
affects
progression
AS
still
need
be
well-known.
This
review
summarizes
molecular
their
emerging
AS,
aimed
at
providing
novel,
promising
druggable
targets
anti-AS
therapy.
Phytotherapy Research,
Год журнала:
2024,
Номер
38(8), С. 3954 - 3972
Опубликована: Июнь 4, 2024
Driven
by
iron-dependent
lipid
peroxidation,
ferroptosis
is
regulated
p53
and
solute
carrier
family
7
member
11
(SLC7A11)/glutathione/glutathione
peroxidase
4
(GPX4)
axis
in
colorectal
cancer
(CRC).
This
study
aimed
to
investigate
the
influence
of
curcumin
(CUR)
on
CRC.
The
efficacies
CUR
malignant
phenotype
CRC
cells
were
determined
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium
bromide,
wound
healing,
clonogenic
assays.
effects
evaluated
transmission
electron
microscopy,
lactate
dehydrogenase
release
assay,
Fe
Frontiers in Cell and Developmental Biology,
Год журнала:
2024,
Номер
12
Опубликована: Март 18, 2024
The
global
challenge
posed
by
cancer,
marked
rising
incidence
and
mortality
rates,
underscores
the
urgency
for
innovative
therapeutic
approaches.
PI3K/Akt
signaling
pathway,
frequently
amplified
in
various
cancers,
is
central
regulating
essential
cellular
processes.
Its
dysregulation,
often
stemming
from
genetic
mutations,
significantly
contributes
to
cancer
initiation,
progression,
resistance
therapy.
Concurrently,
ferroptosis,
a
recently
discovered
form
of
regulated
cell
death
characterized
iron-dependent
processes
lipid
reactive
oxygen
species
buildup,
holds
implications
diseases,
including
cancer.
Exploring
interplay
between
dysregulated
pathway
ferroptosis
unveils
potential
insights
into
molecular
mechanisms
driving
or
inhibiting
ferroptotic
cells.
Evidence
suggests
that
may
sensitize
cells
induction,
offering
promising
strategy
overcome
drug
resistance.
This
review
aims
provide
comprehensive
exploration
this
interplay,
shedding
light
on
disrupting
enhance
as
an
alternative
route
inducing
improving
treatment
outcomes.
Cancers,
Год журнала:
2024,
Номер
16(3), С. 512 - 512
Опубликована: Янв. 24, 2024
Iron
(Fe)
and
copper
(Cu),
essential
transition
metals,
play
pivotal
roles
in
various
cellular
processes
critical
to
cancer
biology,
including
cell
proliferation,
mitochondrial
respiration,
distant
metastases,
oxidative
stress.
The
emergence
of
ferroptosis
cuproptosis
as
distinct
forms
non-apoptotic
death
has
heightened
their
significance,
particularly
connection
with
these
metal
ions.
While
initially
studied
separately,
recent
evidence
underscores
the
interdependence
cuproptosis.
Studies
reveal
a
link
between
accumulation
induction.
This
interconnected
relationship
presents
promising
strategy,
especially
for
addressing
refractory
cancers
marked
by
drug
tolerance.
Harnessing
toxicity
iron
clinical
settings
becomes
crucial.
Simultaneous
targeting
cuproptosis,
exemplified
combination
sorafenib
elesclomol-Cu,
represents
an
intriguing
approach.
Strategies
mitochondria
further
enhance
precision
approaches,
providing
hope
improving
treatment
outcomes
drug-resistant
cancers.
Moreover,
chelators
copper-lowering
agents
established
therapeutic
modalities
exhibits
synergy
that
holds
promise
augmentation
anti-tumor
efficacy
malignancies.
review
elaborates
on
complex
interplay
underlying
mechanisms,
explores
potential
druggable
targets
both
research
settings.